Correction to: Validation of a novel patient reported tool to assess the impact of treatment in erythropoietic protoporphyria: the EPP-QoL
Crossref DOI link: https://doi.org/10.1186/s41687-021-00348-4
Published Online: 2021-08-15
Published Print: 2021-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Biolcati, G.
Hanneken, S.
Minder, E. I.
Neumann, N. J.
Wilson, J. H. P.
Wolgen, P. J.
Wright, D. J.
Lloyd, A. J. http://orcid.org/0000-0002-7597-6556
Text and Data Mining valid from 2021-08-15
Version of Record valid from 2021-08-15
Article History
First Online: 15 August 2021